益生元原料市場－全球產業規模、佔有率、趨勢、機會及預測（按類型、來源、應用、細菌活性、功能、地區和競爭格局分類），2021-2031年

全球益生元成分市場預計將從 2025 年的 74.6 億美元成長到 2031 年的 126.2 億美元，複合年成長率為 9.16%。

該市場涵蓋宿主微生物利用的非消化性化合物，這些化合物能夠帶來健康益處並增強功能。推動這一成長的關鍵因素是預防性醫療保健的普及以及人們對微生物組對整體健康影響（尤其是在免疫功能和腸腦軸方面）的科學認知不斷加深。這些基本促進因素支撐著市場需求，製造商正擴大將益生元纖維添加到膳食補充劑、飲料和機能性食品中，以滿足注重健康的消費者的需求。

然而，該行業面臨著許多挑戰，包括監管的不確定性以及需要嚴格的科學檢驗來支持新的健康聲明。標籤標準和定義的區域差異可能會造成消費者困惑，並阻礙國際貿易。全球益生元協會於2024年對1972名消費者進行的一項調查發現，心理健康是益生元使用者最關注的兩大健康議題之一。這項發現凸顯了提供可靠的臨床證據來檢驗消費者不斷變化的需求並維護長期市場信譽的必要性。

市場促進因素

消費者對微生物組健康和腸道健康的日益關注，正成為市場成長的主要催化劑，並顯著改變他們的購買習慣。消化系統健康與更廣泛的系統性益處（例如心理健康和免疫力）之間的關聯日益緊密，推動著人們從被動治療轉向預防性營養方法。這項轉變得到了強力的科學檢驗，增強了消費者對益生元成分的信任，並鼓勵將其納入日常飲食中。例如，Krasad Biosciences 在 2025 年 11 月發布的報告《回顧 2025：Krasad 的進步之年》中指出，其專有的益生元得到了 125 多篇科學論文的支持，凸顯了推動這一趨勢的廣泛研究。不斷擴大的證據基礎也與消費者賦權相契合。根據 Nuffoods Spectrum Asia 2025 年 2 月發表的一篇文章《健康還是錢包？ 》報導引用了一項調查結果，該調查顯示，近七成消費者認為“健康食品是掌控自己未來健康的一種方式”，這支持了益生元的採用與對自身健康的掌控感之間的聯繫。

對強化飲料和機能性食品日益成長的需求是第二個關鍵促進因素，它推動益生元從利基補充劑市場走向主流零售市場。飲料生產商尤其利用益生元纖維來改良果汁和汽水配方，打造低糖、有益腸道健康的飲品，進而吸引年輕消費者。這種廣泛的應用吸引了大量投資，為品牌快速擴張並進入大型零售商通路奠定了基礎。根據《Inc.》雜誌2025年2月一篇題為「Ollipop完成5000萬美元資金籌措後估值達18.5億美元」的報導報道，益生元汽水公司Ollipop完成了5000萬美元的C輪資金籌措，用於進一步拓展配銷通路和產品開發。這筆資金的湧入顯示了益生元強化產品的商業性潛力，並激勵原料供應商進行創新，以提高這些新劑型中的溶解度和穩定性，確保功能性應用的發展速度超過傳統給藥系統。

市場挑戰

缺乏明確的監管規定和嚴格的科學論證要求，嚴重阻礙了全球益生元原料市場的擴張。生產商被迫在碎片化的環境中運營，不同司法管轄區的標籤標準和定義相互衝突，這不僅阻礙了國際貿易，也增加了遵循成本。這種監管的不確定性常常導致產品上市延遲，迫使企業投入大量資金來滿足各地不同的要求，而非專注於創新。因此，高昂的檢驗成本將小規模企業拒之門外，降低了市場的多樣性和競爭程度。

此外，能否獲得監管部門核准所需的臨床結果存在不確定性，這構成了重大的財務風險。 2024年，全球益生元協會報告稱，在一項對臨床干預措施的系統性回顧中，55.6%的益生元研究顯示，與對照組相比，益生元對生長結果有顯著影響。這項數據凸顯了達到證據標準的固有難度。由於近一半的研究可能無法提供監管機構要求的結論性數據，企業在建立市場信譽所需的大量研發投資方面面臨回報不確定性。

市場趨勢

隨著寵物越來越“擬人化”，飼主也越來越將伴侶動物視為家庭成員，認為它們應該獲得預防性醫療保健。這促使動物用藥品和高階寵物食品中益生元成分的添加成為變革性的趨勢。這種觀點加速了貓狗飲食中腸道健康解決方案的普及，其關注不再局限於簡單的消化，而是擴展到延長壽命和增強免疫力。製造商正積極響應這項需求，開發富含優質益生元纖維（例如甜菜漿和菊苣根）的高階濕糧和乾糧，以此作為功能性宣稱的基礎。根據美國寵物用品協會 (APPA) 於 2025 年 6 月發布的《2025 年犬貓報告》，2024 年功能性犬糧（含有益生菌和益生元）的銷量同比成長 18%，凸顯了消費者對高附加價值營養的快速需求成長。

同時，市場對使用果寡糖和菊糖改善產品質地和減少糖分的需求日益成長。主要原料供應商正利用這些纖維在維持產品質地的同時，滿足嚴格的健康法規要求。除了作為甜味劑外，這些益生元成分還因其能夠在改良產品中重現脂肪和糖的口感而備受青睞，從而解決了「更健康」領域的一項關鍵技術難題。這種雙重效用正推動能夠提供潔淨標示解決方案的製造商實現顯著的收入成長。例如，泰萊公司在2025年5月公佈，截至2025年3月的會計年度，其新產品銷售額年增9%。該公司將這一業績主要歸功於市場對其減糖平台和膳食纖維的強勁需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球益生元原料市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型（寡糖、聚葡萄糖、菊糖、其他）
  • 依成分分類（根莖類、穀類、蔬菜、其他）
  • 按應用領域（食品和飲料、動物飼料、營養補充品）
  • 透過細菌活動（雙歧桿菌、乳酸菌等）
  • 功能性（腸道健康、骨骼健康、心血管健康、體重管理、免疫功能）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美益生元原料市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲益生元原料市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區益生元原料市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲益生元原料市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美益生元原料市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球益生元原料市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Cargill Incorporated
• BENEO GmbH
• Ingredion Incorporated
• Friesland Campina Ingredients
• Tate & Lyle PLC
• Kerry Group plc
• Yakult Honsha Co., Ltd.
• Roquette Freres SA
• Nexira SAS
• Cosucra Groupe Warcoing SA

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Prebiotics Ingredients Market is projected to expand from USD 7.46 Billion in 2025 to USD 12.62 Billion by 2031, reflecting a compound annual growth rate of 9.16%. This market encompasses non-digestible compounds that host microorganisms utilize to generate health or performance advantages. The primary catalysts for this growth are a broad transition toward preventive healthcare and a more profound scientific appreciation of the microbiome's influence on systemic well-being, specifically regarding immune function and the gut-brain axis. These fundamental drivers sustain market demand as manufacturers increasingly integrate prebiotic fibers into dietary supplements, beverages, and functional foods to satisfy health-conscious consumers.

However, the industry encounters significant hurdles regarding regulatory ambiguity and the necessity for strict scientific verification to back emerging health claims. Discrepancies in labeling standards and definitions across different regions can confuse consumers and impede international commerce. According to a 2024 survey by the 'Global Prebiotic Association' involving 1,972 consumers, mental health was identified as one of the top two reported health concerns among users of prebiotics. This finding underscores the essential requirement for solid clinical evidence to validate these shifting consumer priorities and maintain the market's long-term credibility.

Market Driver

Rising consumer awareness regarding microbiome wellness and gut health acts as a major catalyst for market growth, significantly reshaping purchasing habits. Individuals are increasingly associating digestive health with wider systemic advantages, including mental well-being and immunity, prompting a move from reactive treatments toward proactive nutritional approaches. This transition is underpinned by substantial scientific validation, which fosters trust in prebiotic ingredients and promotes their inclusion in daily diets. For example, Clasado Biosciences noted in their November 2025 report, '2025 in review: Clasado reflects on a year of progress,' that their proprietary prebiotic is supported by over 125 scientific publications, highlighting the extensive research driving this movement. This expanding evidence base aligns with consumer empowerment; a February 2025 article in Nuffoods Spectrum Asia titled 'Wellness or the Wallet?' cited a survey where nearly seven out of ten consumers agreed that healthy foods provide control over their future health, confirming the connection between prebiotic adoption and perceived ownership of personal wellness.

The growing demand for fortified beverages and functional foods represents a second crucial driver, extending the presence of prebiotics from niche supplements into mainstream retail sectors. Beverage producers are specifically utilizing prebiotic fibers to reformulate juices and sodas, creating low-sugar, gut-friendly options that resonate with younger consumers. This versatility in application draws substantial investment, allowing brands to rapidly scale and gain placement in major retail outlets. As reported by Inc. Magazine in February 2025, in the article 'Olipop Valued at $1.85 Billion Valuation After $50 Million Fundraise', the prebiotic soda company Olipop closed a $50-million Series C funding round to boost distribution and product development. Such capital inflows demonstrate the commercial potential of prebiotic-fortified products, prompting ingredient suppliers to innovate for better solubility and stability in these new formats, ensuring functional applications grow faster than traditional delivery systems.

Market Challenge

The absence of clear regulations and the strict demand for scientific proof pose a major obstacle to the expansion of the Global Prebiotics Ingredients Market. Producers are forced to operate within a fragmented environment characterized by conflicting labeling standards and definitions across different jurisdictions, which hampers global trade and raises compliance expenses. This regulatory uncertainty frequently postpones product introductions and compels companies to direct significant funds toward satisfying varied regional mandates rather than focusing on innovation. Consequently, the high expense associated with validating claims excludes smaller entities, thereby diminishing overall market diversity and competition.

Moreover, the uncertainty surrounding the acquisition of clinical results required for regulatory approval introduces substantial financial risk. In '2024', the 'Global Prebiotic Association' reported that a systematic review of clinical interventions indicated that 55.6 percent of prebiotic studies showed significant effects on growth outcomes compared to control groups. This statistic emphasizes the inherent difficulties in satisfying evidentiary benchmarks; with nearly half of such studies potentially failing to produce the definitive data regulators demand, companies confront uncertain returns on the extensive research investments necessary to build market credibility.

Market Trends

The incorporation of prebiotic ingredients into animal health and premium pet nutrition is developing as a transformative trend, fueled by the "humanization" of pets, where owners increasingly view companion animals as family members deserving of preventative healthcare. This perspective has accelerated the inclusion of gut-health solutions in feline and canine diets, extending beyond simple digestion to address longevity and immune support. Manufacturers are addressing this demand by creating premium wet foods and kibble enriched with high-quality prebiotic fibers, such as beet pulp and chicory root, to support functional claims. According to the American Pet Products Association's June 2025 'Dog & Cat Report 2025', purchasing data indicated that functional pet diets containing probiotics and prebiotics increased by 18 percent for dogs in 2024, highlighting the swift consumer shift toward value-added nutrition.

Concurrently, the use of oligofructose and inulin for texture enhancement and sugar reduction is growing as major ingredient suppliers utilize these fibers to comply with strict health regulations without sacrificing sensory quality. Beyond their role as sweeteners, these prebiotic ingredients are valued for their capacity to replicate the mouthfeel of fat and sugar in reformulated items, solving a key technical hurdle in the "better-for-you" segment. This dual utility is generating substantial revenue growth for manufacturers capable of providing clean-label solutions. For instance, Tate & Lyle reported in May 2025, within their 'Final Results for the year ended 31 March 2025', that the company's New Product revenue rose by 9 percent on a like-for-like basis, a result largely credited to strong demand for their sugar reduction platforms and dietary fibers.

Key Market Players

• Cargill Incorporated
• BENEO GmbH
• Ingredion Incorporated
• Friesland Campina Ingredients
• Tate & Lyle PLC
• Kerry Group plc
• Yakult Honsha Co., Ltd.
• Roquette Freres S.A.
• Nexira SAS
• Cosucra Groupe Warcoing S.A.

Report Scope

In this report, the Global Prebiotics Ingredients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Prebiotics Ingredients Market, By Type

• Oligosaccharides
• Polydextrose
• Inulin and Others

Prebiotics Ingredients Market, By Source

• Roots
• Grains
• Vegetables and Others

Prebiotics Ingredients Market, By Application

• Food & Beverages
• Animal Feed and Dietary Supplements

Prebiotics Ingredients Market, By Bacterial Activity

• Bifidobacterial
• Lactic Acid Bacteria and Others

Prebiotics Ingredients Market, By Functionality

• Gut Health
• Bone Health
• Cardiovascular Health
• Weight Management and Immunity

Prebiotics Ingredients Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Prebiotics Ingredients Market.

Available Customizations:

Global Prebiotics Ingredients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Prebiotics Ingredients Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Oligosaccharides, Polydextrose, Inulin and Others)
  • 5.2.2. By Source (Roots, Grains, Vegetables and Others)
  • 5.2.3. By Application (Food & Beverages, Animal Feed and Dietary Supplements)
  • 5.2.4. By Bacterial Activity (Bifidobacterial, Lactic Acid Bacteria and Others)
  • 5.2.5. By Functionality (Gut Health, Bone Health, Cardiovascular Health, Weight Management and Immunity)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Prebiotics Ingredients Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Source
  • 6.2.3. By Application
  • 6.2.4. By Bacterial Activity
  • 6.2.5. By Functionality
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Prebiotics Ingredients Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Source
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By Bacterial Activity
      • 6.3.1.2.5. By Functionality
  • 6.3.2. Canada Prebiotics Ingredients Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Source
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By Bacterial Activity
      • 6.3.2.2.5. By Functionality
  • 6.3.3. Mexico Prebiotics Ingredients Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Source
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By Bacterial Activity
      • 6.3.3.2.5. By Functionality

7. Europe Prebiotics Ingredients Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Source
  • 7.2.3. By Application
  • 7.2.4. By Bacterial Activity
  • 7.2.5. By Functionality
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Prebiotics Ingredients Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Source
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By Bacterial Activity
      • 7.3.1.2.5. By Functionality
  • 7.3.2. France Prebiotics Ingredients Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Source
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By Bacterial Activity
      • 7.3.2.2.5. By Functionality
  • 7.3.3. United Kingdom Prebiotics Ingredients Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Source
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By Bacterial Activity
      • 7.3.3.2.5. By Functionality
  • 7.3.4. Italy Prebiotics Ingredients Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Source
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By Bacterial Activity
      • 7.3.4.2.5. By Functionality
  • 7.3.5. Spain Prebiotics Ingredients Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Source
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By Bacterial Activity
      • 7.3.5.2.5. By Functionality

8. Asia Pacific Prebiotics Ingredients Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Source
  • 8.2.3. By Application
  • 8.2.4. By Bacterial Activity
  • 8.2.5. By Functionality
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Prebiotics Ingredients Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Source
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By Bacterial Activity
      • 8.3.1.2.5. By Functionality
  • 8.3.2. India Prebiotics Ingredients Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Source
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By Bacterial Activity
      • 8.3.2.2.5. By Functionality
  • 8.3.3. Japan Prebiotics Ingredients Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Source
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By Bacterial Activity
      • 8.3.3.2.5. By Functionality
  • 8.3.4. South Korea Prebiotics Ingredients Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Source
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By Bacterial Activity
      • 8.3.4.2.5. By Functionality
  • 8.3.5. Australia Prebiotics Ingredients Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Source
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By Bacterial Activity
      • 8.3.5.2.5. By Functionality

9. Middle East & Africa Prebiotics Ingredients Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Source
  • 9.2.3. By Application
  • 9.2.4. By Bacterial Activity
  • 9.2.5. By Functionality
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Prebiotics Ingredients Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Source
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By Bacterial Activity
      • 9.3.1.2.5. By Functionality
  • 9.3.2. UAE Prebiotics Ingredients Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Source
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By Bacterial Activity
      • 9.3.2.2.5. By Functionality
  • 9.3.3. South Africa Prebiotics Ingredients Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Source
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By Bacterial Activity
      • 9.3.3.2.5. By Functionality

10. South America Prebiotics Ingredients Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Source
  • 10.2.3. By Application
  • 10.2.4. By Bacterial Activity
  • 10.2.5. By Functionality
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Prebiotics Ingredients Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Source
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By Bacterial Activity
      • 10.3.1.2.5. By Functionality
  • 10.3.2. Colombia Prebiotics Ingredients Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Source
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By Bacterial Activity
      • 10.3.2.2.5. By Functionality
  • 10.3.3. Argentina Prebiotics Ingredients Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Source
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By Bacterial Activity
      • 10.3.3.2.5. By Functionality

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Prebiotics Ingredients Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Cargill Incorporated
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. BENEO GmbH
• 15.3. Ingredion Incorporated
• 15.4. Friesland Campina Ingredients
• 15.5. Tate & Lyle PLC
• 15.6. Kerry Group plc
• 15.7. Yakult Honsha Co., Ltd.
• 15.8. Roquette Freres S.A.
• 15.9. Nexira SAS
• 15.10. Cosucra Groupe Warcoing S.A.

16. Strategic Recommendations

17. About Us & Disclaimer